ACTBP2 |
|
ACTB pseudogene 2
|
|
|
0.861 |
0.077 |
HPC4 |
|
Prostate cancer, hereditary, 4
|
|
|
0.931 |
0.077 |
ADAD2 |
Q8NCV1
|
adenosine deaminase domain containing 2
|
Enzyme
|
2.4E-12 |
1.000 |
0.077 |
LYRM9 |
A8MSI8
|
LYR motif containing 9
|
|
1.5E-02 |
1.000 |
0.077 |
PPIAP43 |
|
peptidylprolyl isomerase A pseudogene 43
|
|
|
1.000 |
0.077 |
TMA16 |
Q96EY4
|
translation machinery associated 16 homolog
|
|
9.7E-05 |
1.000 |
0.077 |
MIR1827 |
|
microRNA 1827
|
|
|
0.805 |
0.115 |
C3orf35 |
Q8IVJ8
|
chromosome 3 open reading frame 35
|
|
4.9E-02 |
0.821 |
0.115 |
TRPC7 |
Q9HCX4
|
transient receptor potential cation channel subfamily C member 7
|
Ion channel
|
1.9E-04 |
0.839 |
0.115 |
YBX3P1 |
|
Y-box binding protein 3 pseudogene 1
|
|
|
0.805 |
0.115 |
LOC105373985 |
|
delta-like protein 3
|
|
|
0.890 |
0.115 |
OTUD5 |
Q96G74
|
OTU deubiquitinase 5
|
Enzyme
|
1.00 |
0.861 |
0.115 |
RLF |
Q13129
|
rearranged L-myc fusion
|
Enzyme
|
1.00 |
0.931 |
0.115 |
LINC00173 |
Q6ZV60
|
long intergenic non-protein coding RNA 173
|
|
|
0.890 |
0.115 |
LUADT1 |
|
lung adenocarcinoma associated transcript 1
|
|
|
0.861 |
0.115 |
TCEAL9 |
Q9UHQ7
|
transcription elongation factor A like 9
|
Transcription factor
|
0.12 |
0.931 |
0.115 |
DYNLRB1 |
Q9NP97
|
dynein light chain roadblock-type 1
|
Cellular structure
|
0.16 |
0.792 |
0.154 |
TAF1L |
Q8IZX4
|
TATA-box binding protein associated factor 1 like
|
Epigenetic regulator
|
0.96 |
0.839 |
0.154 |
ZDBF2 |
Q9HCK1
|
zinc finger DBF-type containing 2
|
|
1.0E-02 |
0.890 |
0.154 |
PTH2 |
Q96A98
|
parathyroid hormone 2
|
|
2.6E-03 |
0.931 |
0.154 |
ADGRB3 |
O60242
|
adhesion G protein-coupled receptor B3
|
G-protein coupled receptor
|
1.00 |
0.736 |
0.192 |
HYAL3 |
O43820
|
hyaluronidase 3
|
Enzyme
|
3.8E-07 |
0.769 |
0.192 |
IPO9 |
Q96P70
|
importin 9
|
Enzyme modulator
|
1.00 |
0.780 |
0.192 |
SLC4A9 |
Q96Q91
|
solute carrier family 4 member 9
|
Transporter
|
3.2E-22 |
0.839 |
0.192 |
DIP2C |
Q9Y2E4
|
disco interacting protein 2 homolog C
|
|
1.00 |
0.805 |
0.192 |